| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Pablo J. Cagnoni | Pres;Head | 2026-10-15 | 2,642 | $112.71 | $297.78kSell |
| Pablo J. Cagnoni | Pres;Head | 2026-10-15 | 839 | $71.93 | $60.35kBuy |
| Pablo J. Cagnoni | Pres;Head | 2026-10-15 | 423 | $61.76 | $26.12kBuy |
| Pablo J. Cagnoni | Pres;Head | 2026-10-15 | 455 | $61.18 | $27.84kBuy |
| Pablo J. Cagnoni | Pres;Head | 2026-10-15 | 925 | $64.25 | $59.43kBuy |
| Lee Heeson | EVP;Head | 2026-10-01 | 463 | $117.14 | $54.24kSell |
| Edmund Harrigan | Director | 2026-09-30 | 206 | $121.35 | $25.00kBuy |
| Paul J. Clancy | Director | 2026-09-30 | 203 | $121.35 | $24.63kBuy |
| David H. Gardner | CStrat;EVP | 2026-09-22 | 920 | $126.93 | $116.78kSell |
| Pablo J. Cagnoni | Pres;Head | 2026-09-15 | 6,477 | $64.25 | $416.15kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Julian Baker | 9.74% | 19,851,744 | $2.39B | Insider |
| Baker Brothers Life Sciences LP | 6.11% | 12,445,783 | $1.50B | Insider |
| Baker Brothers Life Sciences Capital GP LLC | 6.10% | 12,430,783 | $1.50B | Insider |
| Baker Biotech Capital GP LLC | 2.41% | 4,911,003 | $591.24M | Insider |
| 667 LP | 1.00% | 2,038,937 | $245.47M | Insider |
| Roy A. Whitfield | 0.33% | 666,082 | $80.19M | Insider |
| 14159 Capital GP LLC | 0.32% | 651,582 | $78.44M | Insider |
| Baker Bros Advisors LP | 0.19% | 381,420 | $45.92M | Insider |
| 14159 LP | 0.18% | 370,839 | $44.65M | Insider |
| Herve Hoppenot | 0.17% | 352,703 | $42.46M | Insider |